scholarly journals Myasthenia Gravis With Reversible Pyramidal Tract Damage and Pseudo Internuclear Ophthalmoplegia. A Case Report and Literature Review

2019 ◽  
Vol 10 ◽  
Author(s):  
Yinghong Weng ◽  
Yan Min ◽  
Zhenghe Sheng ◽  
Jia Li ◽  
Dehong Huang
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Myasthenia Gravis ◽  
Pyramidal Tract ◽  
Internuclear Ophthalmoplegia ◽  
Tract Damage

Myasthenia gravis induced by nivolumab in patients with non-small-cell lung cancer: a case report and literature review

Immunotherapy ◽  
2017 ◽  
Vol 9 (9) ◽  
pp. 701-707 ◽  
Author(s):  
Yoshikazu Hasegawa ◽  
Shigeru Kawai ◽  
Takayo Ota ◽  
Hiroshi Tsukuda ◽  
Masahiro Fukuoka
Keyword(s):  
Lung Cancer ◽  
Case Report ◽  
Literature Review ◽  
Myasthenia Gravis ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals Immune Myocarditis Overlapping With Myasthenia Gravis Due to Anti-PD-1 Treatment for a Chordoma Patient: A Case Report and Literature Review

2021 ◽  
Vol 12 ◽  
Author(s):  
Shujing Liang ◽  
Jingxian Yang ◽  
Yun Lin ◽  
Tong Li ◽  
Wenrong Zhao ◽  
...  
Keyword(s):  
Case Report ◽  
Survival Rate ◽  
Side Effects ◽  
Literature Review ◽  
Best Practices ◽  
Adverse Events ◽  
Myasthenia Gravis ◽  
Effective Treatment ◽  
Malignant Tumor ◽  
Clinical Benefit

Immunotherapy begins to be widely used due to the increasing exploration and gratifying effects in multiple cancers. Chordoma, as a rare bone malignant tumor, often recurs and metastasizes after undergoing surgery and radiotherapy. Therefore, immunotherapy can be explored as an emerging, potentially effective treatment to improve the survival rate and clinical benefit of patients. However, a variety of immune-related adverse events (irAEs) cannot be avoided completely. And the immunotherapy-induced myocarditis, as a rare but fatal irAE, has been increasingly reported. Understanding the mechanism involved in irAEs can inform best practices for side effects management. Here, we firstly reported a case of immune myocarditis and subsequent myasthenia gravis (MG) following anti-PD-1 treatment for chordoma.

scholarly journals Castleman Disease Presenting with Pseudotumour Cerebri and Myasthenia Gravis: A Case Report and Literature Review

2018 ◽  
Vol 43 (3) ◽  
pp. 185-191 ◽  
Author(s):  
Alexander S. Fein ◽  
Humberto E. Trejo Bittar ◽  
Manisha R. Shende ◽  
Ernest M. Scalzetti ◽  
Melissa W. Ko
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Myasthenia Gravis ◽  
Castleman Disease ◽  
Pseudotumour Cerebri

scholarly journals The development of myasthenia gravis in a patient with facioscapulohumeral muscular dystrophy: case report and literature review

2019 ◽  
Vol 11 (2) ◽  
Author(s):  
Feryal Nauman ◽  
Muhammad Fawwad Ahmed Hussain ◽  
Ahmet Burakgazi
Keyword(s):  
Health Care ◽  
Case Report ◽  
Muscular Dystrophy ◽  
Literature Review ◽  
Myasthenia Gravis ◽  
Health Care Providers ◽  
Rare Case ◽  
Facioscapulohumeral Muscular Dystrophy ◽  
Care Providers ◽  
Muscle Dystrophy

The co-existence of facioscapulohumeral muscle dystrophy (FSHD) and myasthenia gravis (MG) is very rare and few cases have been described in the literature. To increase the awareness of the health care providers, we present herein a rare case of MG in a patient with FSHD, discuss the diagnostic challenges, pre- and post-treatment findings and provide a literature review.

Sign in / Sign up

Export Citation Format

Share Document